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  Case Presentation 
• History: 34 year-old previously healthy 
Hispanic female was transferred from an 
outlying hospital for concerns of progressive 
rash of two weeks duration with lower 
extremity edema, severe pruritus, arthralgia, 
abdominal pain 
• Past medical history: newly diagnosed with 
hypertension, treated with Hydrochlorothiazide 
for one month 
• Laboratory: UA, CBC, ANCA, ESR, 
Complement, RAF, ANA Panel, Cryoglobulin,  
     HIV, Hepatitis studies were normal 
• Cutaneous Biopsy: Inflammatory infiltration of 
lymphocytes and neutrophils, extravasation of 
erythrocytes, fibrin deposition in the walls of 
the small blood vessels with no evidence of IgA 
antibodies by direct immunofluorescence 
• Treatment: discontinued Hydrochlorothiazide,    
     began high dose IV steroid therapy with  
     transition to oral taper  
• Follow up: patient revealed prolonged recovery 
with continued hyperpigmented lesions and 
peripheral neuropathy  
 
        Discussion   
• Hypersensitivity vasculitis is a clinical syndrome 
due to immune complex deposition in capillaries, 
venules, and arterioles1 
• Clinical symptoms are most commonly palpable 
purpura, but also includes arthralgia, myalgia, 
fever 
• Latent period typically 7-10 days after exposure 
to offending agent 
• Diagnostic Criteria2 
o Age > 16 
o Offending agent  
o Palpable purpura 
o Maculopapular rash 
o Biopsy with neutrophils around 
arterioles/venules 
• Common insulting medications include penicillin, 
cephalosporins, loop diuretics, and thiazide 
diuretics 
• These agents function as a hapten to stimulate an 
immune response3 
• Infections such as hepatitis and HIV have also 
been associated 
• Although an infrequent adverse reaction to a 
regularly prescribed medication, providers  
 must be aware of this risk to provide 
 appropriate treatment and prevent  
 long term sequelae 
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• Cutaneous leukocytoclastic angiitis, or 
hypersensitivity vasculitis, can result from 
treatment by many commonly prescribed 
medications  
• Patients present with various manifestations, 
which may delay diagnosis and appropriate 
treatment 
Punch Biopsy:   
Extravasation of lymphocytes and erythrocytes. 
